Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0714-2018

Drug recall · May 2, 2018

Diltiazem HCl Extended-Release Capsules recall

Why: Failed Dissolution Specifications. High dissolution results were obtained during stability testing.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Diltiazem HCl Extended-Release Capsules, USP 120 mg, 100-count bottles, Rx only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977. NDC: 63739-014-10

Lots / codes

Lot #: 0115086, Exp. 12/2018

Quantity
4266 cartons
Company
Mckesson Packaging Services, Concord, NC
Distribution
Nationwide with the US
Initiated
April 23, 2018 · Voluntary: Firm initiated
Classified
May 7, 2018
Reported
May 2, 2018
Ended
October 13, 2020
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Diltiazem

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.